Skip to content

To study efficacy of kanchnar guggulu along with siravedha in siraj granthi

RANDOMZED OPEN CONTROLLED CLINICAL TRIAL OF SIRAVEDHA WITH AND WITHOUT INTERNAL ADMINISTRATION OF KANCHANARA GUGGULU IN SIRAJAGRANTHI - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074994
Enrollment
84
Registered
2024-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I831- Varicose veins of lower extremities with inflammation

Interventions

None listed

Sponsors

Hon shri annasaheb dange ayurveda medical college and post graduate research centre Ashta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged between 20-70 years (as this condition is commonly noted in these age group), irrespective of sex, caste and religion was selected Patients who are fit for Siravedha. Patients suffering from primary varicose veins

Exclusion criteria

Exclusion criteria: Patients with systemic diseases interfering with the treatment Congenital varicose veins. Siravedha anarhas.

Design outcomes

Primary

MeasureTime frame
Assessment will be done on the basis of subjective paramenters like shool kandu daha and objective parameters like shotha sira vakreekarana twak vaivarnyataTimepoint: Assessment or improvement of parameters will be done on 15th 30th and 45th day of treatment

Secondary

MeasureTime frame
Assessment will be done on the basis of clinical features, subjective and objective parametersTimepoint: Assessment of improvement of features will be done on 15th 30th and 45th day

Countries

India

Contacts

Public ContactDr Akbar Walandkar

Hon Shri Annasaheb Dange Ayurved Medical College And Post Graduate Research Center Ashta

akbar.walandkar@gmail.com9860181980

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026